What are Climb Bio, Inc.'s total assets?

Climb Bio, Inc. (CLYM) holds $152.4M in total assets, down 24.1% year over year.

How much debt does Climb Bio, Inc. have?

Climb Bio, Inc. carries $479.0K in total debt against $148.1M of shareholders' equity, a debt-to-equity ratio of 0.00.

How much cash does Climb Bio, Inc. have?

Climb Bio, Inc. holds $8.4M in cash and equivalents.

Can Climb Bio, Inc. cover its short-term obligations?

Its current ratio is 27.86 — current assets exceed current liabilities.

Where does Climb Bio, Inc.'s balance sheet data come from?

Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Climb Bio, Inc. CLYM Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$35.69M-59.1%	$87.23M-6.3%	$93.11M+114%	$43.59M-7.1%
Short-term investments	$65.4M+2.7%	$63.69M+365%	$13.69M-82.9%	$79.98M-10.7%
Prepaid expenses and other current assets	$4.77M+20.6%	$3.95M+14.3%	$3.46M-68.1%	$10.83M-8.0%
Total current assets	$105.85M-31.7%	$154.87M+40.5%	$110.26M-18.0%	$134.39M-9.3%
Property and equipment, net	$288K+44.7%	$199K—	——	——
Operating lease right-of-use assets	$505K+3.1%	$490K+146%	$199K-57.7%	$471K—
Other non-current assets	$1.53M+9,463%	$16K+6.7%	$15K-88.3%	$128K+82.9%
Total assets	$167.74M-22.8%	$217.19M+96.6%	$110.47M-18.2%	$134.99M-22.1%
Accounts payable	$4.47M+181%	$1.59M-37.5%	$2.54M-38.7%	$4.15M-39.4%
Accrued expenses	$4.46M+9.6%	$4.07M+67.2%	$2.43M-51.8%	$5.05M+9.1%
Operating lease liabilities, current	$256K+63.1%	$157K-53.0%	$334K+11.3%	$300K—
Total current liabilities	$6.98M+41.6%	$4.93M+74.1%	$2.83M-53.5%	$6.1M+1.1%
Operating lease liabilities, non-current	$285K-24.0%	$375K+2,400%	$15K-91.7%	$180K—
Total liabilities	$7.27M+37.0%	$5.31M+84.9%	$2.87M-54.3%	$6.28M+4.0%
Common stock	$5K-28.6%	$7K+133%	$3K0.0%	$3K0.0%
Additional paid-in capital	$449.76M+1.8%	$441.73M+67.6%	$263.58M+5.5%	$249.93M+2.9%
Retained earnings	-$289.73M-26.0%	-$229.88M-47.4%	-$155.98M-29.1%	-$120.86M-59.8%
Accumulated other comprehensive income (loss)	$435K+1,791%	$23K+1,250%	-$2K+99.4%	-$358K-191%
Total stockholders' equity	$160.48M-24.3%	$211.88M+96.9%	$107.6M-16.4%	$128.72M-23.0%
Total liabilities and stockholders' equity	$167.74M-22.8%	$217.19M+96.6%	$110.47M-18.2%	$134.99M-22.1%
Short- term Investments	$65.4M+2.7%	$63.69M+365%	$13.69M-82.9%	$79.98M-10.7%
Deferred Tax Assets and Other Non-Current Assets	$1.53M+9,463%	$16K+6.7%	$15K-88.3%	$128K+82.9%
Net Investment in Lease	$505K+3.1%	$490K+146%	$199K-57.7%	$471K—
Operating lease right-of-use assets	$505K+3.1%	$490K+146%	$199K-57.7%	$471K—
Other non-current assets	$1.53M+9,463%	$16K+6.7%	$15K-88.3%	$128K+82.9%
Operating Lease Right-of-Use Assets in Other Assets	$505K+3.1%	$490K+146%	$199K-57.7%	$471K—
Software and Technology Licenses, Net	$1.53M+9,463%	$16K+6.7%	$15K-88.3%	$128K+82.9%
Accrued expenses and other liabilities	$4.46M+9.6%	$4.07M—	——	——
Total debt	$541K+1.7%	$532K+52.4%	$349K-27.3%	$480K-46.7%
Additional paid-in capital	$449.76M+1.8%	$441.73M+67.6%	$263.58M+5.5%	$249.93M+2.9%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$5K-28.6%	$7K+133%	$3K0.0%	$3K0.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Climb Bio, Inc.'s total assets?: Climb Bio, Inc. (CLYM) holds $152.4M in total assets, down 24.1% year over year.
How much debt does Climb Bio, Inc. have?: Climb Bio, Inc. carries $479.0K in total debt against $148.1M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Climb Bio, Inc. have?: Climb Bio, Inc. holds $8.4M in cash and equivalents.
Can Climb Bio, Inc. cover its short-term obligations?: Its current ratio is 27.86 — current assets exceed current liabilities.
Where does Climb Bio, Inc.'s balance sheet data come from?: Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.